Management of Low-Grade Squamous Intraepithelial Lesion (LSIL) on Colposcopy: LEEP vs. Cryotherapy
For a patient with low-grade squamous intraepithelial lesion (LSIL) on colposcopy twice without prior cryotherapy, cryotherapy should be performed as first-line treatment rather than proceeding directly to LEEP. 1
First-Line Management for LSIL
- Cryotherapy is the preferred first-line treatment for LSIL on colposcopy due to its less invasive nature and lower risk of complications 1
- LSIL has a high spontaneous regression rate (>90% within 24 months), making conservative management often appropriate before considering more invasive procedures 1
- For LSIL preceded by ASC-US or LSIL cytology, follow-up with either HPV DNA testing every 12 months or repeat cervical cytology every 6-12 months is recommended before considering any ablative or excisional procedure 1
- When CIN 1 (LSIL) is identified, observation for up to 24 months using colposcopy and cytology at 6-month intervals is preferred, provided the colposcopic examination is satisfactory and endocervical sampling is negative 2
When LEEP May Be Appropriate for LSIL
LEEP may be appropriate for LSIL in specific circumstances:
- Unsatisfactory colposcopy, when the entire squamocolumnar junction cannot be visualized 1, 3
- Positive endocervical sampling or when endocervical curettage shows dysplasia 1, 4
- Persistent LSIL that persists for at least 2 years despite observation 1, 5
- Recurrent LSIL after previous ablative therapy failure 1
- LSIL preceded by HSIL or AGC-NOS cytology, due to higher risk of missed high-grade lesions 1, 6
- When there is a discrepancy between cytology and colposcopy findings 6
Risks and Benefits Comparison
Cryotherapy Benefits:
- Less invasive procedure with fewer complications 1
- Preserves cervical integrity with no tissue removal 1
- Lower complication rate (approximately 2%) compared to excisional techniques 7
LEEP Benefits and Risks:
- Provides a tissue specimen for histological evaluation, reducing the risk of missing underlying higher-grade lesions 1, 8
- More effective for larger lesions or those extending into the endocervical canal 1
- Higher cure rates (>90%) for lesions of any size compared to ablative techniques 7
- Associated with increased risk of preterm birth in future pregnancies, particularly with multiple procedures 9, 1
- Complication rates range from 5% to 20% 7
Special Considerations
- In a study of patients with repeat LSIL and unsatisfactory colposcopy treated with LEEP, 17.6% were found to have CIN 2-3 on histological examination, indicating a significant risk of underdiagnosed higher-grade lesions 3
- Women of reproductive age should be counseled about increased risks of preterm birth before undergoing LEEP 9
- For adolescents (age ≤20 years), observation rather than immediate treatment is recommended due to very high regression rates 1
- Recent evidence suggests that LEEP-conization may be used without primary biopsy in specific cases including perimenopausal women, extensive abnormalities, discrepancies in test results, and suspicion of invasive cancer 8
Follow-Up Recommendations
- After treatment with either cryotherapy or LEEP, follow-up should include both cytology and HPV testing 3
- Surgical margins cannot be assessed after ablative procedures with cryotherapy; recommended follow-up consists of cervical cytology at 6 months or HPV DNA testing at 12 months 4
- For LEEP with negative margins, cervical cytology at 6 months or HPV DNA testing at 12 months is recommended 4
- The sensitivity of detecting persistent/recurrent disease can reach 90.9% when positive post-treatment HR-HPV or first abnormal cervical cytology after LEEP are found 3
In conclusion, while LEEP provides definitive diagnosis and treatment, cryotherapy remains the preferred first-line approach for LSIL on colposcopy due to its lower complication rate and preservation of cervical integrity. LEEP should be reserved for specific circumstances such as unsatisfactory colposcopy, persistent LSIL, positive endocervical sampling, or when there is suspicion of higher-grade lesions.